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Abstract
Background: Cell adhesion has been shown to induce activation of certain growth factor receptors in a ligand-
independent manner. However, the mechanism for such activation remains obscure.
Methods: Human epidermal carcinoma A431 cells were used as a model to examine the mechanism for adhesion-
induced activation of hepatocyte growth factor receptor Met and epidermal growth factor receptor (EGFR). The
cells were suspended and replated on culture dishes under various conditions. The phosphorylation of Met at
Y1234/1235 and EGFR at Y1173 were used as indicators for their activation. The distribution of the receptors and
lipid rafts on the plasma membrane were visualized by confocal fluorescent microscopy and total internal
reflection microscopy.
Results: We demonstrate that Met and EGFR are constitutively activated in A431 cells, which confers proliferative
and invasive potentials to the cells. The ligand-independent activation of Met and EGFR in A431 cells relies on cell
adhesion to a substratum, but is independent of cell spreading, extracellular matrix proteins, and substratum
stiffness. This adhesion-induced activation of Met and EGFR cannot be attributed to Src activation, production of
reactive oxygen species, and the integrity of the cytoskeleton. In addition, we demonstrate that Met and EGFR are
independently activated upon cell adhesion. However, partial depletion of Met and EGFR prevents their activation
upon cell adhesion, suggesting that overexpression of the receptors is a prerequisite for their self-activation upon
cell adhesion. Although Met and EGFR are largely distributed in 0.04% Triton-insoluble fractions (i.e. raft fraction),
their activated forms are detected mainly in 0.04% Triton-soluble fractions (i.e. non-raft fraction). Upon cell
adhesion, lipid rafts are accumulated at the cell surface close to the cell-substratum interface, while Met and EGFR
are mostly excluded from the membrane enriched by lipid rafts.
Conclusions: Our results suggest for the first time that cell adhesion to a substratum may induce a polarized
distribution of lipid rafts to the cell-substratum interface, which may allow Met and EGFR to be released from lipid
rafts, thus leading to their activation in a ligand-independent manner.
Background
Aberrant activation of receptor tyrosine kinases (RTKs)
is one of the major causes for malignant transforma-
tion [1]. Overexpression, mutation, or deletion of
RTKs can facilitate their activation through a ligand-
independent manner [2]. In particular, constitutive
activation of epidermal growth factor receptor (EGFR)
and/or hepatocyte growth factor receptor Met is often
found in human malignancies, correlated with poor
prognosis [3-5]. Cell-matrix adhesion has been shown
to induce ligand-independent phosphorylation of Met
and EGFR [6]. EGFR forms complexes with integrins
upon cell adhesion, leading to phosphorylation of
EGFR at specific tyrosine residues that are distinct
from those caused by its ligands. In contrast, the phos-
phorylation of EGFR is abolished upon loss of cell
adhesion [7,8]. Likewise, it was reported that the
ligand-independent activation of Met relies on cell
adhesion to fibronectin via a5b1 integrins [9]. How-
ever, the mechanism how cell adhesion activates both
receptors remains poorly understood.
Lipid rafts are highly dynamic, nano-scaled, hetero-
geneous microdomains abundant in cholesterol and
sphingolipid, which function to compartmentalize the
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plasma membrane [10]. Cell-matrix adhesion is
involved in lipid rafts-mediated signal transduction
pathways [11]. For example, integrin a6b4, a laminin
receptor, is incorporated in lipid rafts through palmi-
toylation at cysteine in the membrane-proximal seg-
ment of b4 tail, which subsequently activates a
palmitoylated Src family kinase in the rafts, important
for mitogenic signalling [12]. Additionally, it has been
demonstrated that integrin-mediated adhesion regu-
lates the trafficking of lipid rafts components. Recently,
RalA, a small GTPase, was identified as a key determi-
nant for integrin-dependent membrane rafts trafficking
and regulation of growth signalling [13].
In this study, we set out to examine the mechanism
for adhesion-induced activation of Met and EGFR
using human epidermal carcinoma A431 cells, in
which EGFR and Met are overexpressed and constitu-
tively activated. Possible involvement of matrix pro-
teins, matrix stiffness, integrin b1, Src, reactive oxygen
species (ROS), and the cytoskeleton were examined.
However, none of these was found to be critical for
adhesion-induced activation of Met and EGFR in A431
cells. Instead, we found for the first time that lipid
rafts become accumulated at the cell-substratum inter-
face, which may account, at least in part, for adhesion-
induced activation of Met and EGFR.
Methods
Materials
Polyclonal anti-Met (C12), anti-EGFR (1005), and anti-
ERK were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Monoclonal anti-EGFR pY1173
(#9H2), monoclonal anti-Met (DL-21), and polyclonal
anti-integrin b1 (AB1952) were purchased from Milli-
pore (Billerica, MA). Monoclonal anti-Met pY1234/1235
(D26), polyclonal anti-Met pY1349, and polyclonal anti-
ERK pT202/Y204 were purchased from Cell Signaling
Technology (Beverly, MA). Monoclonal anti-flotillin1
and Matrigel were purchased from BD Biosciences.
Monoclonal anti-EGFR (ab30) was purchased from
Abcam. Monoclonal anti-a-tubulin (DM1A), collagen I,
poly-L-lysine (PLL), ethylene glycol-bis(2-aminoethy-
lether)-N, N, N’, N’-tetraacetic acid (EGTA), N-acetyl-L-
cysteine (NAC), cytochalasin D, nocodazole, and poly-
brene were purchased from Sigma-Aldrich (St Louis,
MO). The mouse ascites containing the monoclonal
anti-Src (peptide 2-17) produced by hybridoma (CRL-
2651) was prepared in our laboratory. Fibronectin, puro-
mycin, and PHA665752 were purchased from Calbio-
chem (La Jolla, CA). Rhodamine-conjugated phalloidin
and Alexa Fluor 488-conjugated cholera toxin subunit B
(CTB-Alexa 488) were purchased from Invitrogen
(Carlsbad, CA). Fetal bovine serum was purchased from
Thermo Scientific HyClone (Logan, UT).
Cell culture
A431 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum and cultured at 37°C in a humidified
atmosphere of 5% CO2 and 95% air. To examine adhe-
sion-induced activation of Met and EGFR, A431 cells
were seeded at 1.5 × 106 per 10-cm dish for 24 h,
referred as attached cells. The attached cells were trypsi-
nized, suspended in serum-free medium for 30 min, and
then replated onto dishes coated with PLL or matrix
proteins for 60 min before lysis. To examine the effect
of cell-cell adhesion on ligand-independent activation of
Met and EGFR, A431 cells were trypsinized and sus-
pended at 2 × 105 cells/ml in serum-free DMEM with
or without 2.5 mM EGTA. After constant rotation at
37°C for 24 h, the cells were lysed in 1% Nonidet P-40
lysis buffer and analysed by immunoblotting.
Immunoblotting
Cells were lysed in 1% Nonidet P-40 lysis buffer (1%
Nonidet P-40, 20 mM Tris-HCl, pH 8.0, 137 mM NaCl,
10% glycerol and 1 mM Na3VO4) containing protease
inhibitors (1 mM phenylmethylsulfonyl fluoride, 0.2
trypsin inhibitory units/ml aprotinin, and 20 μg/ml leu-
peptin). The lysates were centrifuged for 10 minutes at
4°C to remove debris, and the protein concentrations
were determined using the Bio-Rad protein assay (Her-
cules, CA). The total cell lysates were boiled for 3 min-
utes in SDS sample buffer, subjected to SDS-
polyacrylamide gel electrophoresis, and transferred to
nitrocellulose (Schleicher and Schuell). Immunoblotting
was performed with appropriate antibodies using the
Millipore enhanced chemiluminescence system for
detection. Chemiluminescent signals were detected and
quantified by Fuji LAS-3000 luminescence image system.
Lentiviral production and infection
The lentiviral system for short-hairpin RNA (shRNA)
was provided by the National RNAi Core Facility, Aca-
demia Sinica, Taiwan. To produce lentiviruses,
HEK293T cells were co-transfected with 2.25 μg pCMV-
ΔR8.91, 0.25 μg pMD.G, and 2.5 μg hairpin-pLKO.1 by
TransIT-LT1 (Mirus Bio). After 3 days, the medium
containing lentiviral particles was collected and stored
at -80°C. The cells were infected with recombinant lenti-
viruses encoding shRNAs in the medium supplemented
with 8 μg/ml polybrene (Sigma-Aldrich) for 24 h. Subse-
quently, the cells were selected in the growth medium
containing 0.4 μg/ml puromycin and the puromycin-
resistant cells were collected for analysis.
Matrigel invasion assay
The 24-well transwell chambers (Costar) separated by a
membrane with 8-μm pores were coated with 100 μl
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Matrigel (1.6 mg/ml). The lower chamber was loaded
with 750 μl DMEM with 10% serum. The cells were
added to the upper chamber in 250 μl serum-free med-
ium. After 24 h, the cells that had migrated through
Matrigel were stained by Giemsa stain and counted.
Preparation of 2.8 kPa polyacrylamide gel
30% (w/v) acrylamide and 1% (w/v) bis-acrylamide were
prepared as described previously [14,15]. To prepare a
polyacrylamide gel with elastic moduli of 2.8 kPa, acryla-
mide and bis-acrylamide at the final concentrations of
7.5% and 0.1%, respectively, were allowed to be polymer-
ized by addition of TEMED and 10% ammonium persul-
fate. The Mini-PROTEAN III (Bio-Rad) was used to cast
the polyacrylamide gel. When the polymerization is
completed, the gel were transferred to cell culture dishes
and immersed in phosphate-buffered saline (PBS) for
overnight.
Cellular fractionation
The confluent A431 cells in 10-cm dishes were washed
three times with ice-cold PBS and scraped into buffer A
(150 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl pH 7.4,
1 mM PMSF, 5 μg/ml aprotinin) containing 0.04% Tri-
ton X-100 with gentle mixing at 4°C for 10 min. The
lysates were centrifugated at 14,000 × g for 20 min at 4°
C, and the supernatant was transferred to a new eppen-
dorf tube. This fraction is referred as soluble fraction.
The insoluble pellets were resuspended in buffer A con-
taining 1% Triton X-100 for 30 min on ice. Debris was
pelleted after centrifugation at 14,000 × g for 20 min at
4°C, and the supernatant was collected as insoluble
fraction.
Confocal fluorescence microscopy and total internal
reflection fluorescence microscopy
To stain cell surface Met or EGFR, cells were fixed by
4% paraformaldehyde in PBS for 30 min at room tem-
perature, stained with anti-Met (DL-21) or monoclonal
anti-EGFR (ab30) at 4°C overnight, and followed by
Alexa 488-conjugated or Alexa 546-conjugated second-
ary antibodies for 1 h at room temperature. To stain
lipid rafts, cells were rinsed with chilled growth medium
then incubated with 1 μg/ml CTB-Alexa 488 at 4°C for
15 min before fixation in 4% paraformaldehyde. Rhoda-
mine-conjugated phalloidin were used to stain actin fila-
ments. Coverslips were mounted in anti-Fade DAPI-
Fluoromount-G™ (SouthernBiotech; Birmingham, AL)
and viewed using a Zeiss LSM510 laser scanning confo-
cal microscope image system with a Zeiss 100X Plan-
Apochromat objective (NA 1.4 oil). For total internal
reflection fluorescence microscopy, the coverslips were
viewed using an inverted Zeiss microscope (Axio Obser-
ver D1) with a Plan-Fluar 100X/1.45 III objective.
Statistics
Statistical analyses were performed with Student’s t test.
Differences were considered to be statistically significant
at P <0.05.
Results
Ligand-independent activation of Met and EGFR confers
proliferative and invasive advantages to A431 cells
Ligand-independent activation of RTKs as a result of
gene mutation or overexpression is a hallmark of malig-
nant transformation [1]. Overexpression and/or muta-
tion in Met and EGFR have been implicated in the
etiology of a variety of human tumors [5,16]. In this
study, we found that both Met and EGFR are constitu-
tively activated in human epidermal A431 cells (Figure
1a). Depletion of either Met or EGFR in the cells had
adverse effects on their proliferation and invasiveness
(Figures 1b-d). However, the cell proliferation appeared
to rely more on EGFR than on Met (Figure 1c). On the
other hand, the invasiveness of the cells depended more
on Met than on EGFR (Figure 1d). These results suggest
that ligand-independent activation of Met and EGFR
may preferentially contribute to different aspect of
malignant transformation.
Ligand-independent activation of Met and EGFR in A431
cells relies on cell attachment to a substratum, but
independent of cell spreading, ECM proteins, and
substratum stiffness
When the transforming potential of A431 cells was
measured, we noted that A431 cells fail to grow in soft
agar (data not shown). This phenomenon implicated
that the ligand-independent activation of Met and EGFR
in A431 cells might rely on cell adhesion. Indeed, both
Met and EGFR in A431 cells were no longer retained in
the active state when the cells were kept in suspension
(Figure 2a). In the absence of EGTA, the cells were
allowed to aggregate and form large cell masses in sus-
pension. However, even under such a condition, Met
and EGFR were not activated, indicating that ligand-
independent activation of Met and EGFR in A431 cells
relies on cell adhesion to a substratum rather than cell-
cell adhesions.
We reasoned such adhesion-induced activation of Met
and EGFR in A431 cells might be related to cell spread-
ing, cell-matrix interaction, or stiffness of substrata. To
examine the effect of cell spreading, A431 cells were
seeded on culture dishes for 24 hours, referred as
attached cells. To collect cell lysates from suspended
cells, the attached cells were trypsinized, suspended in
serum-free medium, and lyzed. For replating experi-
ments, the suspended cells were replated on dishes
coated with collagen or poly-L-lysine (PLL) for various
intervals. Fifteen min after plating on collagen, the
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activation of Met and EGFR reached the maximum (Fig-
ure 2b). Longer incubation allowed more cells to spread,
but it did not induce more activation in Met and EGFR.
Additionally, the extent of Met and EGFR activation
induced by cell adhesion to PLL was similar to that
induced by cell adhesion to matrix proteins including
collagen and fibronectin (Figure 2c). These results
together indicate that adhesion-induced activation of
Met and EGFR in A431 cells is independent of cell
spreading or cell-matrix interaction. In consistent with
this notion, we found that although shRNA-mediated
depletion of integrin b1 in A431 cells severely impaired
cell-matrix adhesion, it does not affect activation of Met
and EGFR upon cell attachment (Figure 2d). Next, the
effect of substratum stiffness was evaluated. A431 cells
were replated to a polyacrylamide gel which mimics the
stiffness of soft tissues, as described previously [14,15].
Our results showed that attachment of A431 cells to the
polyacrylamide gel induced activation of Met and EGFR
to an extent similar to that induced by cell attachment
to culture dishes (Figure 2e). Our results thus suggest
that substratum stiffness is not a determinant for Met
and EGFR activation in A431 cells.
Adhesion-induced activation of Met and EGFR in A431
cells is independent of Src, ROS, or cytoskeleton
Adhesion-induced activation of RTKs has been attribu-
ted to Src activation [8,17]. However, this is not the
case in A431 cells, because neither Src knockdown (Fig-
ure 3a) nor Src inhibitors (data not shown) affected Met
and EGFR activation upon cell adhesion. Next, we sus-
pected that reactive oxygen species (ROS) or the cytos-
keleton might be involved. Elimination of intracellular
ROS by NAC (Figure 3b) or disruption of actin fila-
ments by cytochalasin D (Figure 3c) and microtubules
by nocodazole (Figure 3d) did not prevent Met and
EGFR activation upon cell adhesion. Therefore, the pos-
sibilities for Src, ROS, and the integrity of cytoskeleton
to play a key role in adhesion-induced activation of Met
and EGFR were excluded.
Figure 1 Ligand-independent activation of Met and EGFR confers proliferative and invasive advantages to A431 cells. (a) An equal
amount of whole cell lysates from epidermal carcinoma A431 cells, lung adenocarcinoma A549 cells, and bladder carcinoma T24 cells was
analyzed by immunoblotting with antibodies as indicated. The activation of Met and EGFR were detected by anti-Met pY1234/1235 (p-Met) and
anti-EGFR pY1173 (p-EGFR). (b) An equal amount of whole cell lysates from the A431 cells stably expressing shRNAs specific to Met (sh-Met
clone #1 and #2), EGFR (sh-EGFR clone #1 and #2) or luciferase (sh-Luc) was analyzed by immunoblotting with anti-Met and anti-EGFR. b-tubulin
was used as an internal control. (c) The cells as described in the panel (b) were seeded on 6-cm dishes and the cell number was counted after
4 days. Data are quantified and expressed as percentage relative to the level of the control A431 cells, which is defined as 100%. Values (means
± s.d.) are from three independent experiments. *p < 0.05 (compared with the sh-Luc). (d) The cells as described in the panel (b) were subjected
to a Matrigel invasion assay. Data are quantified and expressed as percentage relative to the level of the control A431 cells, which is defined as
100%. Values (means ± s.d.) are from three independent experiments. *p < 0.05 (compared with the sh-Luc)
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Figure 2 Cell adhesion induces ligand-independent activation of Met and EGFR. (a) A431 cells were suspended in serum-free medium
with (+) or without (-) 2.5 mM EGTA with constant rotation for 24 hours. Representative images from suspended cells are shown. Scale bar, 150
μm. An equal amount of whole cell lysates was analysed by immunoblotting. (b) A431 cells were seeded on culture dishes for 24 h, referred as
attached cells (att). The attached cells were trypsinized, suspended in serum-free medium for 30 min, and lyzed (sus). For replating experiments,
the suspended cells were replated on dishes coated with 10 μg/ml collagen for various times. The percentage of cell spreading (S) in total
counted cells (n ≥ 200) was measured. Representative images are shown. Scale bar, 50 μm. An equal amount of whole cell lysates was analysed
by mmunoblotting with antibodies as indicated. (c) A431 cells were suspended and then replated on dishes coated with 100 μg/ml poly-L-
lysine (PLL), 10 μg/ml collagen (Col), or fibronectin (FN) for 60 min. The percentage of cell spreading (S) in total counted cells (n ≥ 200) was
measured. Representative images are shown. Scale bar, 50 μm. (d) The attached A431 cells stably expressing shRNAs specific to integrin b1 (sh-
Integrin b1) or luciferase (sh-Luc) were suspended and replated on dishes coated with collagen for 60 min. An equal amount of whole cell
lysates from attached (att), suspended (sus), and replated (rep) cells was analysed by immunoblotting with antibodies as indicated. Scale bar, 50
μm. (e) A431 cells were suspended and then replated onto a culture dish (on dish) or a layer of polyacrylamide gel (on PAA) with elastic moduli
of 2.8 kPa, which mimics the stiffness of soft tissues, in the medium with 1% serum for 3 h. Representative images are shown. Scale bar, 50 μm.
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Figure 3 Adhesion-induced activation of Met and EGFR does not rely on Src, ROS, or cytoskeleton. (a) The control A431 cells and those
stably expressing shRNAs specific to Src (sh-Src) or luciferase (sh-Luc) were kept in suspension for 30 min and replated on dishes coated with
collagen for 60 min. An equal amount of whole cell lysates from attached (att), suspended (sus), and replated (rep) cells was analysed by
immunoblotting with antibodies as indicated. (b) An equal amount of whole cell lysates from attached (att), suspended (sus), and replated (rep)
A431 cells in the presence (+) or absence (-) of 30 mM NAC for 30 min was analysed by immunoblotting with antibodies as indicated. (c) An
equal amount of whole cell lysates from attached (att), suspended (sus), or replated (rep) A431 cells in the presence (+) or absence (-) of 2 μM
cytochalasins D (CD) for 60 min was analysed by immunoblotting with antibodies as indicated. The cells were stained for F-actin with phalloidin.
Representative images for F-actin staining are shown. Scale bar, 20 μm. (d) An equal amount of whole cell lysates from attached (att), suspended
(sus), or replated (rep) A431 cells in the presence (+) or absence (-) of 30 μg/ml nocodazole (NOC) for 60 min was analysed by immunoblotting
with antibodies as indicated. The cells were stained for microtubules with anti-a-tubulin. Representative images are shown. Scale bar, 20 μm.
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Met and EGFR are independently activated upon cell
adhesion
As Met and EGFR have been reported to physically
interact with and activate each other [18-20], we exam-
ined if adhesion-induced activation of Met and EGFR in
A431 cells relies on their mutual activation. We found
that suppression of Met by the specific inhibitor
PHA665752 or shRNA did not affect EGFR activation
upon cell adhesion (Figures 4a and 4b). In addition,
depletion of EGFR did not affect Met activation either
(Figure 4c). Thus, these results indicate that Met and
EGFR in A431 cells are not reciprocally activated upon
cell adhesion.
Overexpression of Met and EGFR is necessary for their
activation upon cell adhesion
Ligand-independent activation of RTKs has been attrib-
uted to their overexpression [21,22]. To examine
whether overexpression of Met and EGFR in A431 cells
is necessary for their activation upon cell adhesion, the
expression of Met or EGFR in A431 cells was sup-
pressed by specific shRNAs. To compare the activation
of the receptors, the phosphorylation of the receptors
was normalized to their expression level. When the
expression of Met or EGFR was reduced, the extent of
Met and EGFR activation was decreased (Figures 5a and
5b). For further examination of the responsiveness to
ligand stimulation, the cells were serum starved for 24
hours and treated with HGF or EGF for 10 min. How-
ever, the reduced level of Met and EGFR retained their
responsiveness to ligand stimulation (Figures 5c and 5d).
Therefore, ligand-independent activation of Met and
EGFR in A431 cells relies on their overexpression in
order for them to be self-activated.
Accumulation of lipid rafts to the cell-substratum
interface may allow activation of Met and EGFR
Lipid rafts have been shown to involve in regulation of
RTK activation [11]. In A431 cells, we found that active
forms of Met and EGFR were mainly detected in the
0.04% Triton-soluble fraction (Figure 6a), suggesting
that Met and EGFR are likely to be activated in non-
lipid rafts. To visualize the distribution of lipid rafts at
the plasma membrane, A431 cells were stained with
Alexa488-conjugated cholera toxin B subunit, which
binds to ganglioside GM1, a lipid-raft marker [23]. Lipid
rafts were distributed randomly at the plasma mem-
brane in suspended cells (Figure 6b). Surprisingly, upon
cell adhesion, lipid rafts became accumulated at the cell
surface close to the cell-substratum interface (Figure
6b), while Met and EGFR were mostly excluded from
the areas enriched by lipid rafts (Figures 7a and 7b).
The fluorescent signals for lipid rafts were confirmed to
be close to the substratum by a total internal refection
Figure 4 Met and EGFR in A431 cells are independently
activated upon cell adhesion. (a) An equal amount of whole cell
lysates from attached (att), suspended (sus), and replated (rep) A431
cells in the presence (+) or absence (-) of 0.5 μM PHA665752 (a
specific inhibitor for Met) for 60 min was analysed by
immunoblotting with antibodies as indicated. (b) The control A431
cells and those stably expressing shRNAs specific to Met (sh-Met) or
luciferase (sh-Luc) were kept in suspension for 30 min and replated
on dishes coated with collagen for 60 min. An equal amount of
whole cell lysates from attached (att), suspended (sus), and replated
(rep) cells was analysed by immunoblotting with antibodies as
indicated. (c) The A431 cells stably expressing shRNAs specific to
EGFR (sh-EGFR clone #1 and #2) or luciferase (sh-Luc) were
suspended in serum-free medium for 30 min and then replated on
dishes coated with collagen for 60 min. An equal amount of whole
cell lysates from attached (att), suspended (sus), and replated (rep)
cells was analysed by immunoblotting with antibodies as indicated.
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Figure 5 Overexpression of Met and EGFR is necessary for their activation upon cell adhesion. (a) The expression of Met in A431 cells
was reduced to different levels by shRNA. The adhesion-induced activation of Met was analysed by normalization of phospho-Met (p-Met) to its
expression level (Met). b-tubulin was used as an internal control. Data (Met and p-Met/Met) are quantified and expressed as percentage relative
to the level of the control A431 cells, which is defined as 100%. Values (means ± s.d.) are from three independent experiments. (b) The
expression of EGFR in A431 cells was reduced to different levels by shRNA. The adhesion-induced activation of EGFR was analysed by
normalization of phospho-EGFR (p-EGFR) to its expression level (EGFR). b-tubulin was used as an internal control. Data (EGFR and p-EGFR/EGFR)
are quantified and expressed as percentage relative to the level of the control A431 cells, which is defined as 100%. Values (means ± s.d.) are
from three independent experiments. (c) The cells as described in (a) were serum-starved for 24 h and treated with HGF (40 ng/ml) for 10 min.
The ligand-induced activation of Met was analysed as described in (a). Data (Met and p-Met/Met) are quantified and expressed as percentage
relative to the level of the control A431 cells, which is defined as 100%. Values (means ± s.d.) are from three independent experiments. (d) The
cells as described in (b) were serum-starved for 24 h and treated with EGF (100 ng/ml) for 10 min. The ligand-induced activation of EGFR was
analysed as described in (b). Data (EGFR and p-EGFR/EGFR) are quantified and expressed as percentage relative to the level of the control A431
cells, which is defined as 100%. Values (means ± s.d.) are from three independent experiments.
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fluorescence microscope, which detect signals ~200 nm
above the coverslip (Figure 6c). These data suggest that
cell adhesion may induce a polarized distribution of
lipid rafts to the cell-substratum interface, which may
allow Met and EGFR to stay out of lipid rafts, leading to
their activation in a ligand-independent manner.
Discussion
Ligand-independent activation of RTKs by cell adhesion
can be important for tumor progression. Upon adhesion
to extracellular matrixes in the tumor microenviron-
ment, tumor cells may acquire growth potential because
of RTK activation. Besides, once tumor cells invade into
blood vessels, they need to attach to endothelial cells for
extravasation. This tumor-endothelium contact might be
sufficient to induce a ligand-independent activation of
RTKs, rendering advantages for tumor cell survival and
metastasis. In this study, we show that ligand-indepen-
dent activation of EGFR and Met is important for prolif-
eration and invasiveness of A431 cells (Figure 1) and
demonstrate such activation relies on cell adhesion to a
substratum (Figure 2a). In our efforts to understand the
underlying mechanism for such activation, we have
excluded the significance of cell spreading, matrix pro-
teins, matrix stiffness, Src, ROS, and cytoskeletal integ-
rity in this process (Figures 2 and 3). Although integrins
Figure 6 Accumulation of lipid rafts at the cell-substratum interface upon cell adhesion. (a) A431 cells were fractionated as described in
Methods. An equal portion of cell lysates from soluble and insoluble fractions was analysed by immunoblotting with antibodies as indicated.
Flotillin1 is used as a marker for lipid rafts. ERK is used as a marker for non-rafts. The phosphorylation of Met and EGFR was measured. Data shown
are representative from two independent experiments. (b) A431 cells were kept in suspension for 30 min and replated on glass coverslips coated
with 100 μg/ml poly-L-lysine for various time as indicated. The cells were stained for lipid rafts with Alexa 488-conjugated cholera toxin B subunit
and visualized by confocal microscopy. Representative XZ and XY images at indicated time are shown. The XY sections were taken at the height of
3.5 μm above the bottom. Scale bar, 5 μm. (c) A431 cells were replated on glass coverslips coated with 100 μg/ml poly-L-lysine for 30 min, stained
for lipid rafts with Alexa 488-conjugated cholera toxin B subunit, and visualized by total internal reflection fluorescence (TIRF) microscopy. The
morphology of the same cell was taken by a differential interference contrast (DIC) objective. Scale Bar, 5 μm.
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have been reported to be important for RTK activation
[24], two lines of evidence from our study indicate that
the integrin-matrix interaction is not responsible for
adhesion-induced activation of Met and EGFR, at least,
in A431 cells. First, cell adhesion to poly-L-lysine is suf-
ficient to activate Met and EGFR (Figure 2c). Second,
depletion of integrin b1 by shRNA does not impair the
attachment-induced activation of Met and EGFR (Figure
2d). However, although our data support that the initial
activation of Met and EGFR upon cell adhesion does
not require the integrin-matrix interaction, it remains
possible that the integrin-matrix interaction may contri-
bute to sustained activation of Met and EGFR.
We found in this study that lipid rafts are randomly
distributed on the plasma membrane of suspended cells,
which are recruited to the ventral surface of the cells
upon cell attachment (Figures 6b and 6c). This is likely
to be a general phenomenon, because it is observed not
only in A431 cells but also in other types of cells such
as SW620 and A549 cells (data not shown). The lipid
rafts enriched at the cell-substratum interface display a
donut-like shape with a diameter of 10-25 μm. This
recruitment can be observed as early as 15 min after
cell adhesion and reach to a plateau at 30-45 min (Fig-
ure 6b). Along with cell spreading, the lipid rafts
become less accumulated at the ventral surface and
eventually distributed more evenly on the whole cell
surface (Figure 6b). Intriguingly, once cell-cell adhesions
are formed, lipid rafts become accumulated at cell-cell
junctions, in particular, tight junctions (data not shown).
Therefore, it is apparent that lipid rafts are dynamic,
whose distribution at the plasma membrane can be dra-
matically changed according to the status of cell adhe-
sions, implicating their roles in various processes.
However, the driving force for lipid rafts to accumulate
at a particular subdomain of the plasma membrane
remains unknown.
As Met and EGFR are mostly activated in the non-
rafts fraction (Figure 6a), it is reasonable to speculate
that the microenvironment within lipid rafts does not
favor the activation of both receptors. Although the
mechanism by which lipid rafts keep Met and EGFR
inactive is not clear, it is possible that the low mem-
brane fluidity of lipid rafts may prevent their self-
Figure 7 Met and EGFR are excluded from the plasma membrane enriched by lipid rafts upon cell adhesion. A431 cells were replated
on glass coverslips coated with 100 μg/ml poly-L-lysine for 30 min and stained for lipid rafts with Alexa 488-conjugated cholera toxin B subunit.
The cells were stained for Met (a) or EGFR (b) with a monoclonal antibody which specifically recognizes the extracellular domain of the
receptors and visualized by confocal microscopy. Arrowheads on the XZ-section images indicate the height at which XY -section images were
taken. Scale Bar, 5 μm.
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association in order to form dimers or oligomers. Alter-
natively, certain negative regulators of Met and EGFR
may be present in lipid rafts, which bind and inhibit the
activation of the receptors. In this study, we found that
while lipid rafts are accumulated at the ventral surface
close to the cell-substratum interface, Met and EGFR
are mostly excluded from the membrane enriched by
lipid rafts (Figure 7). Therefore, the accumulation of
lipid rafts at the ventral surface may be important for
the activation of Met and EGFR. We assume that the
accumulation of lipid rafts to the cell-substratum inter-
face may allow Met and EGFR to be released from lipid
rafts, leading to their activation in the non-raft mem-
brane. However, how lipid rafts become accumulated at
the cell-substratum interface upon cell adhesion and
how Met and EGFR can be excluded from the raft-
enriched membrane upon cell adhesion are currently
unknown. It has been demonstrated that cholesterol
accumulation, which breaks down the homeostasis of
the plasma membrane, leads to coalescence of lipid rafts
and induces a more malignant phenotype in prostate
cancers [25,26]. Therefore, it is evident that the consitu-
tion and distribution of lipid rafts are closely linked to
RTK activaiton and cellular trasnformation.
Conclusions
Ligand-independent activation of Met and EGFR in
A431 cells relies on cell attachment to a substratum, but
is independent of cell spreading, extracellular matrix
proteins, and substratum stiffness. This cell attachment-
induced activation of Met and EGFR cannot be attribu-
ted to Src activation, ROS production, and the integrity
of the cytoskeleton. Instead, overexpression of the
receptors is a prerequisite for their self-activation upon
cell attachment. Moreover, we demonstrate that Met
and EGFR are independently activated upon cell attach-
ment. Finally, sequestration of lipid rafts at the cell-sub-
stratum interface may allow Met and EGFR to be
activated in the non-raft membrane upon cell adhesion.
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